Abstract
RIG-I–like receptors (RLRs) are known as viral RNA sensors that trigger the antiviral interferon (IFN) response by the recognition of the nonself signatures in viral RNAs, including 5’ triphosphate structure and double-strand. Self-RNAs generally escape their recognition by several modifications such as 5’ cap; however, it has recently been shown that endogenous RNAs without an adenosine deaminase ADAR1-dependent modification aberrantly activate RLR signalling and lead to severe IFN signature, resulting in autoimmune disorders. Also gain-of-function mutations of RLRs have been found in patients with autoimmune diseases. We herein provide a recent overview of the RLR-mediated antiviral IFN response and autoimmunity and discuss how atypical activation of RLRs triggers autoimmune diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ablasser A et al (2014) TREX1 deficiency triggers cell-autonomous immunity in a cGAS-dependent manner. J Immunol 192:5993–5997. doi:10.4049/jimmunol.1400737
Berke IC, Yu X, Modis Y, Egelman EH (2012) MDA5 assembles into a polar helical filament on dsRNA. Proc Natl Acad Sci U S A 109:18437–18441. doi:10.1073/pnas.1212186109
Bursztejn AC et al (2015) Unusual cutaneous features associated with a heterozygous gain-of-function mutation in IFIH1: overlap between Aicardi-Goutieres and Singleton-Merten syndromes. Br J Dermatol 173:1505–1513. doi:10.1111/bjd.14073
Cai X, Chiu YH, Chen ZJ (2014) The cGAS-cGAMP-STING pathway of cytosolic DNA sensing and signaling. Mol Cell 54:289–296. doi:10.1016/j.molcel.2014.03.040
Crampton SP, Deane JA, Feigenbaum L, Bolland S (2012) Ifih1 gene dose effect reveals MDA5-mediated chronic type I IFN gene signature, viral resistance, and accelerated autoimmunity. J Immunol 188:1451–1459. doi:10.4049/jimmunol.1102705
Crow YJ, Rehwinkel J (2009) Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity. Hum Mol Genet 18:R130–R136. doi:10.1093/hmg/ddp293
Crow YJ et al (2006) Mutations in the gene encoding the 3’-5’ DNA exonuclease TREX1 cause Aicardi-Goutieres syndrome at the AGS1 locus. Nat Genet 38:917–920. doi:10.1038/ng1845
Cunninghame Graham DS et al (2011) Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus. PLoS Genet 7, e1002341. doi:10.1371/journal.pgen.1002341
Funabiki M et al (2014) Autoimmune disorders associated with gain of function of the intracellular sensor MDA5. Immunity 40:199–212. doi:10.1016/j.immuni.2013.12.014
Gack MU et al (2007) TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446:916–920. doi:10.1038/nature05732
Gao D et al (2015) Activation of cyclic GMP-AMP synthase by self-DNA causes autoimmune diseases. Proc Natl Acad Sci U S A 112:E5699–E5705. doi:10.1073/pnas.1516465112
Gray EE, Treuting PM, Woodward JJ, Stetson DB (2015) Cutting Edge: cGAS Is Required for Lethal Autoimmune Disease in the Trex1-Deficient Mouse Model of Aicardi-Goutieres Syndrome. J Immunol 195:1939–1943. doi:10.4049/jimmunol.1500969
Hornung V et al (2006) 5’-Triphosphate RNA is the ligand for RIG-I. Science 314:994–997. doi:10.1126/science.1132505
Hou F et al (2011) MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 146:448–461. doi:10.1016/j.cell.2011.06.041
Jang MA et al (2015) Mutations in DDX58, which encodes RIG-I. Cause atypical Singleton-Merten syndrome. Am J Human Genet 96:266–274. doi:10.1016/j.ajhg.2014.11.019
Kageyama M et al (2011) 55 Amino acid linker between helicase and carboxyl terminal domains of RIG-I functions as a critical repression domain and determines inter-domain conformation. Biochem Biophys Res Commun 415:75–81. doi:10.1016/j.bbrc.2011.10.015
Kato H et al (2006) Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101–105. doi:10.1038/nature04734
Kato H et al (2008) Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 205:1601–1610. doi:10.1084/jem.20080091
Kawai T et al (2005) IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 6:981–988. doi:10.1038/ni1243
Kawane K et al (2006) Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature 443:998–1002. doi:10.1038/nature05245
Kowalinski E et al (2011) Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA. Cell 147:423–435. doi:10.1016/j.cell.2011.09.039
Liddicoat BJ et al (2015) RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself. Science 349:1115–1120. doi:10.1126/science.aac7049
Marques JT et al (2006) A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells. Nat Biotechnol 24:559–565. doi:10.1038/nbt1205
Meylan E et al (2005) Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:1167–1172. doi:10.1038/nature04193
Napirei M et al (2000) Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat Genet 25:177–181. doi:10.1038/76032
Narita R et al (2014) A novel function of human Pumilio proteins in cytoplasmic sensing of viral infection. PLoS Pathog 10, e1004417. doi:10.1371/journal.ppat.1004417
Nejentsev S, Walker N, Riches D, Egholm M, Todd JA (2009) Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 324:387–389. doi:10.1126/science.1167728
Ng CS et al (2013) Encephalomyocarditis virus disrupts stress granules, the critical platform for triggering antiviral innate immune responses. J Virol 87:9511–9522. doi:10.1128/JVI.03248-12
Oda H et al (2014) Aicardi-Goutieres syndrome is caused by IFIH1 mutations. Am J Hum Genet 95:121–125. doi:10.1016/j.ajhg.2014.06.007
Onoguchi K et al (2010) Virus-infection or 5’ppp-RNA activates antiviral signal through redistribution of IPS-1 mediated by MFN1. PLoS Pathog 6, e1001012. doi:10.1371/journal.ppat.1001012
Onomoto K et al (2012) Critical role of an antiviral stress granule containing RIG-I and PKR in viral detection and innate immunity. PLoS One 7, e43031. doi:10.1371/journal.pone.0043031
Oshiumi H et al (2010) The ubiquitin ligase Riplet is essential for RIG-I-dependent innate immune responses to RNA virus infection. Cell Host Microbe 8:496–509. doi:10.1016/j.chom.2010.11.008
Peisley A, Wu B, Yao H, Walz T, Hur S (2013) RIG-I forms signaling-competent filaments in an ATP-dependent, ubiquitin-independent manner. Mol Cell 51:573–583. doi:10.1016/j.molcel.2013.07.024
Pestal K et al (2015) Isoforms of RNA-editing enzyme ADAR1 independently control nucleic acid sensor MDA5-driven autoimmunity and multi-organ development. Immunity 43:933–944. doi:10.1016/j.immuni.2015.11.001
Pichlmair A et al (2006) RIG-I-mediated antiviral responses to single-stranded RNA bearing 5’-phosphates. Science 314:997–1001. doi:10.1126/science.1132998
Rice GI et al (2014) Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling. Nat Genet 46:503–509. doi:10.1038/ng.2933
Robinson T et al (2011) Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN-alpha and serologic autoimmunity in lupus patients. J Immunol 187:1298–1303. doi:10.4049/jimmunol.1100857
Rutsch F et al (2015) A specific IFIH1 gain-of-function mutation causes Singleton-Merten syndrome. Am J Hum Genet 96:275–282. doi:10.1016/j.ajhg.2014.12.014
Sato M et al (2000) Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13:539–548
Satoh T et al (2010) LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses. Proc Natl Acad Sci U S A 107:1512–1517. doi:10.1073/pnas.0912986107
Schlee M et al (2009) Recognition of 5’ triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 31:25–34. doi:10.1016/j.immuni.2009.05.008
Seth RB, Sun L, Ea CK, Chen ZJ (2005) Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122:669–682. doi:10.1016/j.cell.2005.08.012
Takeuchi O, Akira S (2010) Pattern recognition receptors and inflammation. Cell 140:805–820. doi:10.1016/j.cell.2010.01.022
Van Eyck L et al (2015) Brief report: IFIH1 mutation causes systemic Lupus Erythematosus with selective IgA deficiency. Arthritis Rheumatol 67:1592–1597. doi:10.1002/art.39110
Wang Y et al (2010) Structural and functional insights into 5’-ppp RNA pattern recognition by the innate immune receptor RIG-I. Nat Struct Mol Biol 17:781–787. doi:10.1038/nsmb.1863
Wu B et al (2013) Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5. Cell 152:276–289. doi:10.1016/j.cell.2012.11.048
Xu LG et al (2005) VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 19:727–740. doi:10.1016/j.molcel.2005.08.014
Yang YG, Lindahl T, Barnes DE (2007) Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease. Cell 131:873–886. doi:10.1016/j.cell.2007.10.017
Yoneyama M et al (2004) The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5:730–737. doi:10.1038/ni1087
Yoneyama M et al (2005) Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 175:2851–2858
Yoneyama M, Onomoto K, Jogi M, Akaboshi T, Fujita T (2015) Viral RNA detection by RIG-I-like receptors. Curr Opin Immunol 32C:48–53. doi:10.1016/j.coi.2014.12.012
Yoo JS et al (2014) DHX36 enhances RIG-I signaling by facilitating PKR-mediated antiviral stress granule formation. PLoS Pathog 10, e1004012. doi:10.1371/journal.ppat.1004012
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Japan
About this chapter
Cite this chapter
Kato, H., Fujita, T. (2016). Aberrant Activation of RIG-I–Like Receptors and Autoimmune Diseases. In: Miyasaka, M., Takatsu, K. (eds) Chronic Inflammation. Springer, Tokyo. https://doi.org/10.1007/978-4-431-56068-5_39
Download citation
DOI: https://doi.org/10.1007/978-4-431-56068-5_39
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-56066-1
Online ISBN: 978-4-431-56068-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)